跳至主要内容
临床试验/ITMCTR2000003288
ITMCTR2000003288已完成未知

The Clinical Efficacy and Safety of ''clear lung detoxification soup'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19) at Different Time Points: A Retrospective Study

Institute of Basic Research for Clinical Medicine, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • Comply with the diagnostic criteria for general type COVID-19 in the Diagnosis and Treatment Program for COVID-19(trial Inclusion criteria version 5th)

排除标准

  • 1. Patients who can not guarantee compliance of using TCM during the treatment period, or patients who are difficult to take medicine by oral or nasal route;
  • 2. Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19;
  • 3. Maternal, or patients with a positive urine pregnancy test;
  • 4. People with malignant tumors, mental diseases and other systemic malignant diseases;
  • 5. Those who are allergic to the test drug and those who are intolerant to the drug.

研究者

发起方
Institute of Basic Research for Clinical Medicine, China Academy of Chinese Medical Sciences

相似试验